Related Experiment Video
Updated: Aug 3, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
The pathology of hypertrophic cardiomyopathy
1Department of Histopathology, Royal Free and University College Medical School, University College London and UCL Hospitals NHS Trust, London, UK. sian.hughes@ucl.ac.uk
Insights
Sudden cardiac death (SCD) in young individuals can be the first sign of hypertrophic cardiomyopathy (HCM). Accurate pathological diagnosis of HCM is vital for families, requiring cardiac screening and genetic counseling.
Area of Science:
- Cardiovascular Pathology
- Medical Genetics
Background:
- Sudden cardiac death (SCD) is a devastating outcome, particularly in young, asymptomatic individuals.
- Hypertrophic cardiomyopathy (HCM) is an inherited myocardial disease that can lead to SCD and may present asymptomatically.
- Pathological diagnosis is often the first encounter with HCM, highlighting its silent nature.
Purpose of the Study:
- To review the pathological diagnosis of hypertrophic cardiomyopathy (HCM).
- To discuss recent advances in the genetics of HCM.
- To identify common pitfalls in HCM diagnosis and reduce diagnostic uncertainty.
Main Methods:
- Review of pathological diagnostic criteria for HCM.
- Synthesis of current research on genetic underpinnings of HCM.
- Analysis of diagnostic challenges and potential resolutions.
Main Results:
- HCM diagnosis relies on characteristic pathological findings of left ventricular hypertrophy.
- Genetic mutations are increasingly identified as causative factors in HCM.
- Diagnostic uncertainty can arise from overlapping conditions and subtle pathological changes.
Conclusions:
- Prompt and accurate pathological diagnosis of HCM is crucial for affected families.
- Genetic screening and counseling are essential for families with HCM.
- Understanding diagnostic pitfalls improves clinical and pathological identification of HCM.
Abstract:
Sudden cardiac death (SCD) is devastating at any age, but even more so when the individual affected is young and asymptomatic, and the death is entirely unexpected. SCD is a catastrophic complication of hypertrophic cardiomyopathy (HCM) and may be the first manifestation of this disease. HCM is an inherited intrinsic disease of the myocardium characterized by left ventricular hypertrophy without chamber dilatation, in the absence of either a systemic or other cardiac disease, which may cause a similar magnitude of hypertrophy. HCM may be a clinically silent disease. Indeed, the pathologist may be the first to encounter a case of HCM at autopsy. HCM has wide-ranging implications for affected families, who will require cardiac screening and genetic counselling even if mutations are not known. Therefore, prompt and accurate diagnosis of HCM is vital. This review article will focus on the pathological diagnosis of HCM, recent advances in the genetics of this disease, and common pitfalls which may arise, leading to diagnostic uncertainty.
Related Concept Videos
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cellular Adaptation II: Hypertrophy

